Capitalization 10.64B 11.53B 15.91B P/E ratio 2024 *
23.3x
P/E ratio 2025 * 20.9x
Enterprise value 11.62B 12.59B 17.38B EV / Sales 2024 *
5.17x
EV / Sales 2025 * 4.77x
Free-Float
46.85%
Yield 2024 *
2.71%
Yield 2025 * 2.98%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.88%
1 week+1.47%
Current month+6.47%
1 month+5.39%
3 months-1.43%
6 months+4.28%
Current year+6.18%
More quotes
1 week
50.65
Extreme 50.65
52.00
1 month
48.22
Extreme 48.22
52.00
Current year
47.28
Extreme 47.28
53.40
1 year
43.04
Extreme 43.04
53.40
3 years
34.52
Extreme 34.52
57.90
5 years
28.26
Extreme 28.26
57.90
10 years
11.30
Extreme 11.3
57.90
More quotes
Insider TitleAgeSince
Chief Executive Officer 62 21-11-30
Director of Finance/CFO 54 19-10-31
Chief Tech/Sci/R&D Officer - 17-06-30
Insider TitleAgeSince
Chairman 52 98-04-28
Director/Board Member 53 14-04-16
Director/Board Member 55 18-06-11
More insiders
Name Weight AuM 1st Jan change Investor Rating
1.52% 5 M€ +12.55%
More ETFs: Recordati
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+0.88%+1.47%+14.38%+1.19% 11.45B
-2.10%-5.05%+87.21%+253.55% 791B
-2.16%-6.97%+62.71%+216.13% 595B
+2.58%-0.19%-8.65%-9.07% 367B
+1.24%+0.02%+15.75%+63.02% 315B
+1.77%+0.54%+23.07%+49.60% 306B
+0.07%+5.64%-0.40%-21.25% 247B
+0.20%+0.94%+13.41%+44.03% 244B
+0.08%-2.67%+5.47%+13.82% 218B
+0.71%-0.02%+42.56%+36.94% 179B
Average +0.28%-0.51%+25.55%+64.80% 327.3B
Weighted average by Cap. -0.32%-1.99%+38.88%+114.86%
See all sector performances

Financials

Ratios2024 *2025 *
Net sales 2.3B 2.5B 3.44B 2.44B 2.65B 3.65B
Net income 474M 513M 709M 522M 565M 780M
Net Debt 1.25B 1.36B 1.88B 1.01B 1.1B 1.51B
More financial data * Estimated data
Logo Recordati
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows: - pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.; - medicines for rare diseases (32.1%). Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Employees
4,455
Calendar
More about the company
Date Price Change Volume
24-07-24 51.85 +0.88% 236 790
24-07-23 51.40 0.00% 276,286
24-07-22 51.40 +0.88% 201,991
24-07-19 50.95 -0.59% 206,976
24-07-18 51.25 -0.97% 287,873

Real-time Borsa Italiana, July 24, 2024 at 11:44 am

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
51.85EUR
Average target price
52.64EUR
Spread / Average Target
+1.52%
Consensus